home / stock / kdny / kdny news


KDNY News and Press, Chinook Therapeutics Inc Com

Stock Information

Company Name: Chinook Therapeutics Inc Com
Stock Symbol: KDNY
Market: NASDAQ
Website: chinooktx.com

Menu

KDNY KDNY Quote KDNY Short KDNY News KDNY Articles KDNY Message Board
Get KDNY Alerts

News, Short Squeeze, Breakout and More Instantly...

KDNY - Earnings week ahead: Cisco, Walmart, Target, Home Depot and more

2023-08-13 08:02:00 ET More on Cisco, Deere, etc. Compare metrics for CSCO to DE, HD, SNDL, TGT, WMT Walmart: The Bottom Could Fall Out If Inflation Levels Continue To Fall Home Depot: Long-Term Winner, With Room To Run Target estimates lowered at Barclays ah...

KDNY - Chinook Therapeutics Inc. (NASDAQ: KDNY) Highlighted for Surprising Price Action

Chinook Therapeutics, Inc. (NASDAQ: KDNY) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 2.86% on the day to $40.3. Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, dev...

KDNY - Chinook Therapeutics gains as HSR waiting period expires in Novartis deal

2023-08-01 08:51:10 ET Chinook Therapeutics ( NASDAQ: KDNY ) rose almost 3% in premarket trading after the Hart-Scott Rodino antitrust waiting period for its planned sale to Novartis ( NYSE: NVS ) expired. The HSR wating period for the sale of Chinook ( KDNY ) ...

KDNY - Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy

SEATTLE, July 28, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the first patient with IgA nephropathy (IgAN) has been enr...

KDNY - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, KDNY, FRG

NEW YORK, NY / ACCESSWIRE / July 27, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Sculptor Capital Management Inc. (NYS...

KDNY - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CIR, KDNY, FRG, SGTX

NEW YORK, NY / ACCESSWIRE / July 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CIRCOR International, Inc. (NYSE: CIR...

KDNY - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMED, KDNY, SGTX

NEW YORK, NY / ACCESSWIRE / July 20, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Amedisys, Inc. (NASDAQ:AMED)'s sale...

KDNY - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, CWBR, EMAN, GHL

NEW YORK, NY / ACCESSWIRE / July 19, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chinook Therapeutics, Inc. (NASDAQ...

KDNY - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, PRDS

NEW YORK, NY / ACCESSWIRE / July 18, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chinook Therapeutics, Inc. (NASDAQ:KD...

KDNY - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, AEL, KDNY, FRG

NEW YORK, NY / ACCESSWIRE / July 13, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Denbury Inc. (NYSE:DEN)'s sale to Ex...

Next 10